Zoetis (ZTS) Receivables - Other (2012 - 2025)

Zoetis (ZTS) has 14 years of Receivables - Other data on file, last reported at $69.0 million in Q4 2025.

• Receivables - Other for Q4 2025 came in at $69.0 million, down 12.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $69.0 million (down 12.66% YoY), and the FY2025 annual result was $69.0 million, down 12.66% from the prior year.
• Receivables - Other fell to $69.0 million in Q4 2025 per ZTS's latest filing, from $79.0 million in the prior quarter.
• Over five years, Receivables - Other peaked at $79.0 million in Q4 2024 and troughed at $47.0 million in Q4 2021.
• A 5-year average of $64.8 million and a median of $69.0 million in 2025 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other soared 51.06% in 2022, then fell 18.31% in 2023.
• A 5-year view of Receivables - Other shows it stood at $47.0 million in 2021, then surged by 51.06% to $71.0 million in 2022, then fell by 18.31% to $58.0 million in 2023, then jumped by 36.21% to $79.0 million in 2024, then retreated by 12.66% to $69.0 million in 2025.
• Business Quant data shows ZTS's Receivables - Other at $69.0 million in Q4 2025, $79.0 million in Q4 2024, and $58.0 million in Q4 2023.